Sponsor Pipeline

Faeth Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06463028 Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an… Endometrial Cancer Recruiting
Phase 1/2
NCT07558733 Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2… HR+ HER2- Breast Cancer Recruiting
Disease Areas
Endometrial Cancer (1) Breast Cancer (1)
Get alerts when Faeth Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free